Clean Room Lessons from FDA’s Compounding Pharmacy Inspections
This article was originally published in The Gold Sheet
Executive Summary
Reacting to last fall’s fungal meningitis crisis, FDA has inspected more than 50 compounding pharmacies this year looking for poor aseptic practices. What it found makes for a sobering training tool on sterility assurance.